Heart failure trials in Austria
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Vienna
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Graz, Innsbruck, Linz, Vienna
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Linz
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Braunau am Inn, Graz, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Braunau Am Inn, Graz, Klagenfurt Am Woerthersee, Linz, Salzburg, St. Poelten, Vienna
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Linz, Vienna
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - No phaseTaking peopleBIO|STREAM.CSP Study
- Where
- Linz
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT07393009 - No phaseTaking peopleCytOSorb TreatMent Of Critically Ill PatientS Registry
- Where
- Klagenfurt, Vienna
- People
- 3,000 worldwide
- Run by
- CytoSorbents, Inc
See details and how to joinNCT05146336 - No phaseTaking peopleThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Where
- Vienna
- Age
- 18 years and over
- People
- 754 worldwide
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370 - No phaseEnrolling by invitationGlobal Utilization And Registry Database for Improved heArt preservatioN
- Where
- Graz, Vienna
- People
- 4,000 worldwide
- Run by
- Paragonix Technologies
See details and how to joinNCT04141605 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Linz, Vienna
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Bad Ischl, Braunau am Inn, Graz, Linz, Saint Stefan/Stainz, Salzburg, Sankt Pölten, Vienna, Vöcklabruck
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Bad Ischl, Feldkirch, Graz, Innsbruck, Klagenfurt Am Woerthersee, Linz, St. Poelten, St. Stefan ob Stainz, Vienna, Wels
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - No phaseEnrolling by invitationSnapshot Study on Patients With Heart Failure
- Where
- Graz, Salzburg
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- European Society of Cardiology
See details and how to joinNCT06469814 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705 - No phaseTaking peopleAlleviant ALLAY-HF Study
- Where
- Graz
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT05685303 - No phaseTaking peopleEarly Detection and IntervenTion in Heart Failure
- Where
- Vienna
- Age
- 65 years and over
- People
- 18,000 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07731490 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Vienna
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - No phaseTaking peopleBIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
- Where
- Graz
- Age
- 18 years to 99 years
- People
- 151 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT07360158 - No phaseNot yet taking people in AustriaSTRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in Complex PCI
- Where
- Vienna
- Age
- 18 years and over
- People
- 50
- Run by
- Rayyan Hemetsberger
See details and how to joinNCT07588399 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Salzburg, Vienna
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseTaking peopleNoninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
- Where
- Vienna
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Thomas Schlöglhofer, PhD, MSc
See details and how to joinNCT04641416 - No phaseTaking peopleTelemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome
- Where
- Innsbruck
- Age
- 18 years and over
- People
- 162
- Run by
- Medical University Innsbruck
See details and how to joinNCT07391683 - No phaseTaking peopleCorheart 6 LVAS Study
- Where
- Graz, Vienna
- Age
- 18 years to 75 years
- People
- 53 worldwide
- Run by
- Shenzhen Core Medical Technology CO.,LTD.
See details and how to joinNCT05876000